The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ELEVATION ONCOLOGY INC | COM | 28623U101 | 14,268 | 2,370,142 | SH | SOLE | 2,370,142 | 0 | 0 | ||
| ICOSAVAX INC | COM | 45114M109 | 80,314 | 3,510,228 | SH | SOLE | 3,510,228 | 0 | 0 | ||
| JASPER THERAPEUTICS INC | COM | 471871103 | 45,946 | 5,852,982 | SH | SOLE | 5,852,982 | 0 | 0 | ||
| KEZAR LIFE SCIENCES INC | COM | 49372L100 | 13,856 | 828,711 | SH | SOLE | 828,711 | 0 | 0 | ||
| TALARIS THERAPEUTICS INC | COM | 87410C104 | 44,840 | 2,932,606 | SH | SOLE | 2,932,606 | 0 | 0 | ||
| VENTYX BIOSCIENCES INC | COM | 92332V107 | 18,079 | 910,306 | SH | SOLE | 910,306 | 0 | 0 | ||
